Literature DB >> 23816980

Exposures from nuclear medicine diagnostic procedures: the dose impact on the Aosta Valley population.

S Aimonetto1, C Arrichiello, A Peruzzo Cornetto, P Catuzzo, M Zeverino, C Poti, T Meloni, M Pasquino, S Tofani.   

Abstract

The present work evaluates the per-procedure, annual collective and per-capita effective doses to the Aosta Valley region population from nuclear medicine (NM) examinations performed from 2005 to 2011 at the regional NM department. Based on its demographical and socioeconomics characteristics, this area can be considered as representative of the level I countries, as defined by the United Nations Scientific Committee on the Effects of Atomic Radiation. The NM per-procedures effective doses were within the range of 0.018-35 mSv. A steady frequency per 10 000 inhabitants has been observed, together with a decrease for thyroid and whole-body bone scintigraphy. Myocardial and bone scintigraphy studies were the major contributors to the total collective effective dose. The mean annual collective and per-capita effective doses to the population were 15 man Sv y(-1) and 120 µSv y(-1), respectively. The NM contribution to the total per-capita effective dose accounts for 5.9 % of that due to the medical ionising radiation examinations overall.

Entities:  

Mesh:

Year:  2013        PMID: 23816980     DOI: 10.1093/rpd/nct158

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  The contribution of interventional cardiology procedures to the population radiation dose in a 'health-care level I' representative region.

Authors:  Andrea Peruzzo Cornetto; Stefania Aimonetto; Francesco Pisano; Marcello Giudice; Marco Sicuro; Teodoro Meloni; Santi Tofani
Journal:  Radiat Prot Dosimetry       Date:  2015-05-25       Impact factor: 0.972

2.  Estimating the population dose from nuclear medicine examinations towards establishing diagnostic reference levels.

Authors:  Fatemeh Niksirat; Ali Shabestani Monfared; Mohammad Reza Deevband; Mehrangiz Amiri; Amir Gholami
Journal:  Indian J Nucl Med       Date:  2016 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.